Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C Group Study

Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C Group Study

Introduction. Hepatitis C virus genotype 4 is predominant in the Middle East and Northern Africa, even if it has recently spread to Southern Europe. Data about the treatment of post-liver transplantation (LT) genotype 4 hepatitis C recurrence are scarce. We report a retrospective analysis of post-LT...

Full description

Bibliographic Details
Main Authors: Francesca Romana Ponziani, Alessandro Milani, Antonio Gasbarrini, Raffaella Zaccaria, Raffaella Viganò, Maria Francesca Donato, Maria Cristina Morelli, Lucia Miglioresi, Luisa Pasulo, Maria Rendina, Daniele Di Paolo, Maria Marino, Pierluigi Toniutto, Stefano Fagiuoli, Maurizio Pompili
Format: Article
Language:English
Published: Elsevier 2012-05-01
Series:Annals of Hepatology
Subjects:
HCV recurrence
Liver transplantation
HCV treatment
Genotype 4
EVR
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119309299

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119309299

Similar Items